Cardiovascular & Hematological Disorders-Drug Targets
Title:Editorial: Growing Researches Responding to the Booming of Cardiovascular and Metabolic Diseases in China and Canada
Volume: 18 Issue: 1
Author(s): Garry X. Shen
Affiliation:
Export Options
About this article
Cite this article as:
Shen X. Garry, Editorial: Growing Researches Responding to the Booming of Cardiovascular and Metabolic Diseases in China and Canada, Cardiovascular & Hematological Disorders-Drug Targets 2018; 18 (1) . https://dx.doi.org/10.2174/1871529X1801180516171921
DOI https://dx.doi.org/10.2174/1871529X1801180516171921 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
26
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Use of the Adamantane Structure in Medicinal Chemistry
Current Medicinal Chemistry Adult Neurogenesis and the Diseased Brain
Current Medicinal Chemistry Update on the Imaging Techniques in the Diagnosis of Diabetic Retinopathy
Current Diabetes Reviews Leptin: A Promising Therapeutic Target with Pleiotropic Action Besides Body Weight Regulation
Current Drug Targets Timing of Tracheostomy in Patients with Intracerebral Haemorrhage: A Propensity-Matched Analysis
Current Neurovascular Research Beta-Blockers in Children with Congenital Heart Disease Before a Corrective Procedure
Reviews on Recent Clinical Trials subject Index To Volume 1
Current Medicinal Chemistry Radix Angelica Sinensis Promotes Synaptic Plasticity During Cognitive Recovery in Chronically Stressed Rats
Current Neurovascular Research Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery
Current Topics in Medicinal Chemistry Properties and Distribution of Angiotensin I Converting Enzyme
Current Pharmaceutical Design After 10 Years of Clinical Trials with Liraglutide in Diabetes, What do we Know About its Effects on Clinical Cardiovascular Outcomes?
Reviews on Recent Clinical Trials Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Phosphonic Esters and their Application of Protease Control
Current Pharmaceutical Design Adenosine and Adenosine 5’-triphosphate Catabolism in Systemic Blood as a Potential Biomarker for Doxorubicin Cardiotoxicity in an Experimental Rat Model in vivo
Cardiovascular & Hematological Disorders-Drug Targets Fluid and Electrolyte Disorders in the Newborn: Sodium and Potassium
Current Pediatric Reviews Physiology and Pathophysiology of Na+/H+ Exchange Isoform 1 in the Central Nervous System
Current Neurovascular Research A Practical Comprehensive Approach to Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Implications of Prion Protein Biology
Current Neurovascular Research Pentraxin Level is the Key to Determine Primary Percutaneous Coronary Intervention (PCI) or Fibrinolysis
Cardiovascular & Hematological Disorders-Drug Targets Prediction of Bioactive Compound Pathways Using Chemical Interaction and Structural Information
Combinatorial Chemistry & High Throughput Screening